BUTAPASTE- phenylbutazone paste 
Butler Animal Health Supply LLC dba Henry Schein Animal Health

----------

PHENYLBUTAZONE PASTE
for Horses

NDC 11695-4851-1

ANADA 200-266, Approved by the FDA.

For Veterinary Use Only

DESCRIPTION: Phenylbutazone Paste is a synthetic, non-hormonal anti-inflammatory, antipyretic compound useful in the management of inflammatory conditions. The apparent analgesic effect is probably related mainly to the compound's anti-inflammatory properties. Chemically, Phenylbutazone Paste is 4-butyl-1, 2-diphenyl-3, 5-pyrazolidinedione. It is a pyrazolone derivative, entirely unrelated to the steroid hormones.

INDICATIONS: For the relief of inflammatory conditions associated with the musculoskeletal systems in horses.

CONTRAINDICATIONS: Use with caution in patients who have a history of drug allergy.

WARNING: Not for use in horses intended for food.

PRECAUTIONS: Stop medication at the first sign of gastrointestinal upset, jaundice, or blood dyscrasia. Authenticated cases of agranulocytosis associated with the drug have occurred in man; fatal reactions, although rare, have been reported in dogs after long-term therapy. To guard against this possibility, conduct routine blood counts at weekly intervals during the early phase of therapy and at intervals of two weeks thereafter. Any significant fall in the total white blood cell count, relative decrease in granulocytes, or black or tarry stools should be regarded as a signal for immediate cessation of therapy and institution of appropriate counter-measures. In the treatment of inflammatory conditions associated with infections, specific anti-infective therapy is required.

ADMINISTRATION AND DOSAGE: Orally - 1 to 2 g of phenylbutazone per 500 lb. of body weight daily. Do not exceed 4 g daily.

Guidelines to Successful Therapy: Use a relatively high dose for the first 48 hours, then reduce gradually to a maintenance dose. Maintain the lowest dose capable of producing desired clinical response. Response to Phenylbutazone Paste therapy is prompt, usually occurring within 24 hours. If no significant clinical effect is evident after five days, re-evaluate diagnosis and therapeutic approach.

When administering Phenylbutazone Paste, the oral cavity should be empty. Deposit paste on back of tongue by depressing plunger that has been previously set to deliver the correct dose. Many chronic conditions will respond to Phenylbutazone Paste therapy, but discontinuance of treatment may result in recurrence of symptoms.

STORAGE: Store at 15°-30°C (59°-86°F).

HOW SUPPLIED: Syringes containing 20 g of Phenylbutazone.

KEEP OUT OF REACH OF CHILDREN

CAUTION: Federal (U.S.A.) law restricts this drug to use by or on the order of a licensed veterinarian.

Manufactured by:
Med-Pharmex, Inc.
Pomona, CA 91767-1861
rev 06/12

PRINCIPAL DISPLAY PANEL - 60 mL Syringe Label

HENRY SCHEIN®
ANIMAL HEALTH

NDC #11695-4851-1

ANADA #200-266, Approved by FDA

BUTAPASTE
Phenylbutazone Paste for Horses

FOR VETERINARY USE ONLY

APPLE FLAVOR

Each syringe contains 20 g phenylbutazone.

Each 3 mL marking on the plunger contains Phenylbutazone: 1 g.

Indications: For the relief of inflammatory conditions associated
with the musculoskeletal system in horses.

Dosage: 1 to 2 g of phenylbutazone per 500 lb body weight, but not
to exceed 4 g daily. Oral cavity should be empty. Deposit paste on
the back of tongue by depressing plunger that has been previously
set to deliver the correct dose.

WARNING: Not for use in horses intended for food.

CAUTION: Federal (U.S.A.) law restricts this drug to use by or on
the order of a licensed veterinarian.

KEEP OUT OF REACH OF CHILDREN

See package insert for additional information.

Store at 15°-30°C (59°-86°F).

Net Volume: 60 mL

Reorder #044015

Distributed Exclusively by
Henry Schein Animal Health
Dublin, OH 43017

www.henryscheinvet.com

HENRY SCHEIN
SEAL OF EXCELLENCE

VetUS™

Lot #/Exp. Date:

Rev. 06/13

PRINCIPAL DISPLAY PANEL - 60 mL Syringe Label
BUTAPASTE 
phenylbutazone paste
Product Information
Product TypePRESCRIPTION ANIMAL DRUGItem Code (Source)NDC:11695-4851
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
Phenylbutazone (UNII: GN5P7K3T8S) (Phenylbutazone - UNII:GN5P7K3T8S) Phenylbutazone35.1 g  in 100 g
Product Characteristics
Color    Score    
ShapeSize
FlavorAPPLEImprint Code
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:11695-4851-160 g in 1 SYRINGE
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
ANADAANADA20026608/14/2012
Labeler - Butler Animal Health Supply LLC dba Henry Schein Animal Health (017880659)
Registrant - Vetoquinol USA, Inc. (106824209)
Establishment
NameAddressID/FEIBusiness Operations
Med-Pharmex, Inc.025353699MANUFACTURE
Establishment
NameAddressID/FEIBusiness Operations
Sintenovo SA DE CV812039808API MANUFACTURE

Revised: 6/2016
Document Id: bb1445f4-304d-4bae-975c-ab5d09776fbe
Set id: 53f5e51e-94c1-4f0e-b4d3-30f423b1c6db
Version: 1
Effective Time: 20160627
 
Butler Animal Health Supply LLC dba Henry Schein Animal Health